Partner Headlines - TEVA

  1. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets
  2. How Will Healthcare Stocks Be Affected If Donald Trump Wins?

    Dividend.com
  3. How Will Healthcare Stocks Be Affected If Hillary Clinton Wins?

    Dividend.com
  4. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily
  5. California Leads Nation In Tech, Lifesciences IPOs

    IBD
  6. Gurus Are Buying High-Yield Stocks Like WestRock, Target

    GuruFocus
  7. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  8. Takeda Provides Update About New Business Venture in Japan with ...

    Benzinga
  9. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus
  10. NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical

    GuruFocus
  11. Benzinga's Top Initiations

    Benzinga
  12. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD
  13. Benzinga's Volume Movers

    Benzinga
  14. Top Performing Industries For December 1, 2015

    Benzinga
  15. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  16. Teva Announces Proposed Public Offerings Of Amer Depositary Shrs ...

    Benzinga
  17. Teva, Takeda Establish Partnership in Japan; Teva to Own 51% ...

    Benzinga
  18. Teva, Heptares Announce Agreement to Discover and Develop Novel, ...

    Benzinga
  19. Benzinga's Top Upgrades

    Benzinga
  20. Pfizer, Allergan Set To Unveil $150 Billion Inversion

    IBD
  21. John Paulson Increases Holding in Teva Pharmaceutical

    GuruFocus
  22. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus
  23. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD
  24. Ronald Muhlenkamp's Highest-Yielding Stocks

    GuruFocus
  25. Teva Announces Breakthrough Therapy Designation for SD-809 Granted ...

    Benzinga
  26. Allergan Beats Q3 Estimates Amid M&A, Pricing Talk

    IBD
  27. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  28. Allergan Confirms Pfizer Talks

    IBD
  29. Teva Pharmaceutical's

    IBD
  30. Ah the Joys of Theft - My Purloined Portfolio

    GuruFocus
  31. Here's Why Biotechs Fell On Monday

    Benzinga
  32. Teva Launches Generic Avodart Capsules in the US

    Benzinga
  33. Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps

    IBD
  34. Acorda, Allergan Make Surprise Deal On Ampyra Patent

    IBD
  35. Benzinga's M&A Chatter for Thursday October 1, 2015

    Benzinga
  36. Allergan Guidance Update Gets Mixed Reception

    IBD
  37. U.S. M&A Hits Record As Companies Try To Grow Sales

    IBD
  38. Teva Announces COPAXONE Approved in Japan for Prevention of Relapse ...

    Benzinga
  39. Teva Presents New Reslizumab Data at ERS International Congress ...

    Benzinga
  40. Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, ...

    GuruFocus
  41. An ETF That Provides Shelter From Stormy Markets

    Benzinga
  42. Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic ...

    Benzinga
  43. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings ...

    Benzinga
  44. Allergan Modestly Tops Views

    IBD
  45. Allergan Q2 Beats, But Generics Sale Clouds Outlook

    IBD
  46. Israeli Tech Startups Attract Record Funding In Q2

    IBD
  47. 5 Top Medical Stocks Reporting Earnings This Week

    IBD
  48. Teva's Deal-Making Spurs Inflows To Israel ETFs

    Benzinga
  49. Benzinga's Top Upgrades

    Benzinga
  50. IBD 50: 10 Top Stocks Reporting Earnings This Week

    IBD
  51. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD
  52. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD
  53. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD
  54. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  55. Stocks In Rebound Mode; Icon, Cadence Break Out

    IBD
  56. Can Health Care Sector Continue its Incredible Run?

    FoxBusiness
  57. Weekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA

    GuruFocus
  58. Benzinga's Top Upgrades

    Benzinga
  59. Teva Announces European Medicines Agency (EMA) Confirms Successful ...

    Benzinga
  60. Teva Prefers Allergan Unit

    IBD
  61. Benzinga's M&A Chatter for Monday July 27, 2015

    Benzinga
  62. Stocks Fall For Fifth Straight Session On China Woes

    IBD
  63. Allergan CEO: Teva Made A 'Compelling Offer' We Couldn't Refuse

    Benzinga
  64. Market Update: Monday's Top 10 Volume Movers

    Benzinga
  65. Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces

    IBD
  66. Market Update: Monday's Mid-Day Movers, China's Stock Market ...

    Benzinga
  67. Stocks In The Red But Off Lows As Shanghai, Europe Weigh

    IBD
  68. Teva Drops Mylan Chase To Buy Allergan Generics Unit

    IBD
  69. Benzinga's Volume Movers

    Benzinga
  70. Teva Confirms Allergan Generics Buy, Drops Mylan Bid

    IBD
  71. U.S. Stocks On Track For Weak Open As Chinese Stocks Sink

    IBD
  72. UPDATE: Mylan Issues Comment on Teva Deal to Buy Allergan's Generic ...

    Benzinga
  73. UPDATE: Teva Withdraws Proposal to Acquire Mylan

    Benzinga
  74. UPDATE: Teva to Acquire Allergan Generics for $40.5 B

    Benzinga
  75. Benzinga's Weekend M&A Chatter

    Benzinga
  76. Teva To Buy Allergan's Generic Drug Unit, Unit Worth ~$45B, Deal ...

    Benzinga
  77. Biotech IPO Boom Gaining Thrust With NantKwest Debut

    IBD
  78. Morning-after pill use increases

    IBD
  79. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD
  80. Rapid7 IPO Pops 52%; Investors Hungry For Blue Buffalo

    IBD
  81. Painkiller Abuse Drives Drugmakers To Innovate

    IBD
  82. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  83. Teva-Mylan merger opposed

    IBD
  84. Benzinga's Top Initiations

    Benzinga
  85. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD
  86. Momenta Pharma

    IBD
  87. Momenta Downgraded After Stock Price Doubles

    IBD
  88. Teva-Xenon Arthritis Pain Drug Fails Midstage Trial

    IBD
  89. Wednesday's Mid-Day Movers: Chubb, Rock Creed, RADA Win; Peabody ...

    Benzinga
  90. Unusual Covered Call Opportunity Teva Pharmaceuticals

    Benzinga
  91. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD
  92. New America's IPO Stock Winners: Fitbit, Arista

    IBD
  93. ObamaCare Enables Health Insurer Merger Mania

    IBD
  94. Paul Tudor Jones Buys Stakes in ADP and Visa

    GuruFocus
  95. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  96. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  97. Teva to Present New Findings at the American Headache Society ...

    Benzinga
  98. How High Can Eagle Pharmaceuticals Fly On Teva Deal?

    IBD
  99. Teva's Mylan bid hits snag

    IBD
  100. Teva's Auspex Buyout Pays, But Mylan Bid Hits Snag

    IBD
Trading Center